TuisOCEAW • NASDAQ
add
Ocean Biomedical
Vorige sluiting
$0,033
Dagwisseling
$0,030 - $0,045
Jaarwisseling
$0,020 - $0,68
Markkapitalisasie
6,82 m USD
Gemiddelde volume
68,95 k
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | — | — |
Bedryfskoste | 768,00 k | -71,07% |
Netto inkomste | -5,53 m | 60,76% |
Netto winsgrens | — | — |
Wins per aandeel | — | — |
EBITDA | — | — |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | — | — |
Totale bates | 1,13 m | 9,80% |
Totale aanspreeklikheid | 99,22 m | 30,11% |
Totale ekwiteit | -98,08 m | — |
Uitstaande aandele | 34,87 m | — |
Prys om te bespreek | -0,01 | — |
Opbrengs op bates | -128,73% | — |
Opbrengs op kapitaal | 2,46% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | -5,53 m | 60,76% |
Kontant van bedrywe | -885,00 k | 21,68% |
Kontant van beleggings | — | — |
Kontant van finansiering | 896,00 k | — |
Netto kontantverandering | 11,00 k | 100,97% |
Beskikbare kontantvloei | 1,62 m | 294,11% |
Meer oor
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Gestig
2019
Webwerf
Werknemers
7